Credit Suisse Ag Agenus Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$0.63 - $1.14 $15,513 - $28,071	-24,624 Reduced 4.8%	488,190 $405,000
Q3 2023 Nov 13, 2023	SELL	$1.12 - $1.88 $67,184 - $112,773	-59,986 Reduced 10.47%	512,814 $579,000
Q2 2023 Aug 11, 2023	BUY	$1.31 - $2.04 $454,205 - $707,312	346,722 Added 153.36%	572,800 $916,000
Q1 2023 May 10, 2023	BUY	$1.45 - $2.95 $101 - $206	70 Added 0.03%	226,078 $343,000
Q4 2022 Feb 13, 2023	SELL	$2.02 - $3.25 $39,412 - $63,410	-19,511 Reduced 7.95%	226,008 $542,000
Q3 2022 Nov 10, 2022	SELL	$1.96 - $3.14 $285,987 - $458,163	-145,912 Reduced 37.28%	245,519 $503,000
Q2 2022 Aug 12, 2022	SELL	$1.3 - $2.64 $6,835 - $13,881	-5,258 Reduced 1.33%	391,431 $759,000
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $20,727 - $30,605	8,820 Added 2.27%	396,689 $976,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $128,170 - $251,951	43,894 Added 12.76%	387,869 $1.25 Million
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $772,517 - $1.03 Million	155,124 Added 82.14%	343,975 $1.81 Million
Q2 2021 Aug 16, 2021	BUY	$2.56 - $5.49 $35,863 - $76,909	14,009 Added 8.01%	188,851 $1.04 Million
Q1 2021 May 14, 2021	SELL	$2.69 - $5.25 $497,138 - $970,252	-184,810 Reduced 51.39%	174,842 $476,000
Q4 2020 Feb 12, 2021	BUY	$3.17 - $4.49 $260,754 - $369,333	82,257 Added 29.65%	359,652 $1.14 Million
Q3 2020 Nov 13, 2020	SELL	$2.98 - $5.2 $162,845 - $284,159	-54,646 Reduced 16.46%	277,395 $1.11 Million
Q2 2020 Aug 12, 2020	BUY	$2.29 - $4.24 $529,560 - $980,495	231,249 Added 229.43%	332,041 $1.31 Million
Q1 2020 May 13, 2020	SELL	$1.92 - $4.39 $37,804 - $86,439	-19,690 Reduced 16.34%	100,792 $247,000
Q4 2019 Feb 12, 2020	BUY	$2.41 - $4.4 $140,642 - $256,775	58,358 Added 93.94%	120,482 $491,000
Q3 2019 Nov 12, 2019	SELL	$2.17 - $3.14 $5,902 - $8,540	-2,720 Reduced 4.19%	62,124 $159,000
Q2 2019 Aug 14, 2019	BUY	$2.53 - $3.04 $3,701 - $4,447	1,463 Added 2.31%	64,844 $194,000
Q1 2019 May 14, 2019	BUY	$2.51 - $3.73 $39,070 - $58,061	15,566 Added 32.55%	63,381 $188,000
Q4 2018 Feb 13, 2019	BUY	$1.59 - $2.66 $15,901 - $26,602	10,001 Added 26.45%	47,815 $113,000
Q3 2018 Nov 13, 2018	SELL	$1.59 - $2.42 $34,712 - $52,833	-21,832 Reduced 36.6%	37,814 $81,000
Q2 2018 Aug 14, 2018	SELL	$2.26 - $4.65 $34,033 - $70,024	-15,059 Reduced 20.16%	59,646 $136,000
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $48,595 - $83,623	13,845 Added 22.75%	74,705 $352,000
Q4 2017 Feb 14, 2018	BUY	$3.26 - $4.78 $8,785 - $12,882	2,695 Added 4.63%	60,860 $198,000
Q3 2017 Nov 14, 2017	BUY	$3.48 - $4.44 $138,166 - $176,281	39,703 Added 215.05%	58,165 $256,000
Q2 2017 Aug 14, 2017	BUY	N/A	18,462	18,462 $72,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account